Romsons Group

Romsons Group of Industries is a leading manufacturer of disposable medical devices. We have pioneered in the field of disposable medical devices with the largest product portfolio in the industry (100 products in over 400 sizes), which caters to almost the entire spectrum of patient need. Designed and manufactured to deliver maximum performance and safety, Romsons is the last word in quality. Most significantly, the name Romsons continues to inspire trust - for unsurpassed quality, innovation & safety of its products.

Sahajanand Medical Technologies

At SMT (Sahajanand Medical Technologies), we are revolutionizing healthcare through innovation and clinical excellence. As a multinational MedTech company with diversified manufacturing facilities and operations across multiple countries, SMT is at the forefront of high-end cardiovascular, endovascular, and structural heart devices. Guided by our mission, “Pledged to Save Millions,” we specialize in developing clinically proven solutions for coronary interventions, occluders for congenital defects, and structural heart therapies. Our products undergo rigorous clinical trials and are featured in world-class medical journals like The Lancet, New England Journal of Medicine, BMJ Open, and JACC, cementing our position as a trusted leader in evidence-based healthcare. With a presence in 80+ countries and a diverse global workforce, SMT is driving innovation to meet the needs of healthcare professionals and patients. Our cutting-edge technologies are designed to tackle complex anatomies, high-risk cases, and challenging clinical scenarios, enhancing procedural outcomes and improving patients’ quality of life. As an emerging leader in the MedTech industry, we are committed to advancing healthcare standards and shaping the future of interventional cardiology.

Neodent

Neodent is a global brand available in more than 90 countries, founded by a dentist for dentists with the purpose of changing patients’ lives. With a legacy of 30 years focused on ease of use, Neodent Dental Implant Systems focus on progressive treatment concepts, such as immediacy with modern and reliable solutions to enable therapy access and affordability for creating new smiles every day.

Terumo Medical Corporation

Our Promise At Terumo, everything starts with our unwavering commitment to patients. Listening sincerely to their needs and deeply understanding their hopes and aspirations, we boldly pursue innovative ways to help enhance the lives of patients around the world. Our Promise Story Terumo was founded by a group of physicians and scientists to support the lives of people. Ever since then, we have been doing all we can to advance healthcare and enhance patients’ quality of life. This mindset, expressed in our Group Mission, “Contributing to Society through Healthcare,” drives our continuous transformation to do even more. We will listen sincerely to patients’ needs and deepen our understanding of their hopes and aspirations to discover what will be truly beneficial for them. We will work more closely with healthcare professionals and partners pursuing innovative solutions and ways to advance patient care together. And we will continue to expand our activities and take on new challenges with the thoughts and feelings of patients in mind. We are driven by our desire to help improve patients’ lives. By putting this unwavering commitment into action, we will realize a better future for healthcare and patients.

OrbusNeich Medical Company Ltd.

OrbusNeich is a major global medical device manufacturer specialized in interventional instruments for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, OrbusNeich sells products to over 70 countries and regions worldwide, and it is also the only PCI balloon manufacturer headquartered in China that ranked among the top 6 players in all major overseas PCI balloon markets including Japan, Europe and the U.S. According to an industry research report, in terms of sales volume of PCI balloons in 2021, OrbusNeich held an over 50% share of the PCI balloon market in Hong Kong, and ranked No. 2 in Japan, No. 4 in Europe, No. 6 in the PRC and No. 6 in the U.S . In addition, in terms of sales volume of PTA balloons in 2021, it ranked No. 3 in Japan and No. 4 in the U.S. In addition to PCI/PTA balloons, it also specializes in coronary stent products and is actively expanding into neuro vascular intervention and structural heart disease areas. OrbusNeich owns more than 180 granted patents globally. Its in-house R&D team has over twenty years of product development experience and has developed proprietary, world leading technologies, including its Scoreflex NC product, the world’s smallest profile non-compliant scoring balloon; its proprietary “drug plus antibody” COMBO dual therapy stent; and its JADE non-compliant peripheral balloon, the first and only non-compliant over-the-wire PTA balloon approved by the FDA that is compatible with all guidewire systems in the U.S. OrbusNeich is listed on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEX”), under the stock code 6929. For more information and news, visit http://www.orbusneich.com/ or follow us on Twitter @OrbusNeich (Last updated on 23rd Dec 2022)